当前位置: X-MOL 学术Pol. Arch. Intern. Med. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Time-to-treatment failure and peripheral eosinophils in non-small cell lung cancer patients treated with immune checkpoint inhibitors.
Polish Archives of Internal Medicine ( IF 5.218 ) Pub Date : 2021-06-28 , DOI: 10.20452/pamw.16049
Hajime Osawa 1 , Toshihiro Shiozawa 1 , Shinichiro Okauchi 2 , Kunihiko Miyazaki 3 , Takahide Kodama 3 , Katsunori Kagohashi 2 , Ryota Nakamura 4 , Hiroaki Satoh 5 , Nobuyuki Hizawa 1
Affiliation  

There is an unmet clinical need to identify biomarkers to predict which non-small cell lung cancer (NSCLC) patients will benefit from immune checkpoint inhibitor (ICPI) treatment.

中文翻译:

接受免疫检查点抑制剂治疗的非小细胞肺癌患者的治疗失败时间和外周嗜酸性粒细胞。

识别生物标志物以预测哪些非小细胞肺癌 (NSCLC) 患者将从免疫检查点抑制剂 (ICPI) 治疗中受益的临床需求尚未得到满足。
更新日期:2021-06-30
down
wechat
bug